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PURPOSE. To better understand the relationship of lamina cribrosa (LC) and choroid features to
the severity of pseudoexfoliation glaucoma (PXG).
METHODS. In this cross-sectional study, 137 eyes of 122 subjects (47 eyes with moderate/
advanced PXG [mean deviation (MD), 15.0 6 7.7 dB], 34 eyes with mild PXG [MD, 2.7 6
1.5 dB], 32 aged-matched pseudoexfoliation syndrome [PXS] eyes, and 24 aged-matched
control eyes) were investigated. Optic discs, LC thickness, and anterior LC depth (ALD;
midsuperior, center, and midinferior) as well as peripapillary choroidal thickness were
determined. Linear mixed modeling was used to adjust for age, sex, and axial length.
RESULTS. A progressive decrease in LC thickness was found when comparing controls (271.9
6 61.3 lm), PXS (212.6 6 51.5 lm), mild PXG (180.8 6 24.6 lm), and moderate/advance
PXG (138.9 6 37.5 lm) (P < 0.001). ALD was greater (P < 0.001) in moderate/advance
glaucoma (306.7 6 105.3 lm) and mild PXG (209.5 6 79.7 lm) compared with PXS (155 6
86.7 lm) and healthy controls (149.2 6 103 lm). Although eyes with moderate/advance PXG
had the thinnest choroid (117.2 6 36.6 lm), choroidal thickness was comparable in mild
PXG, PXS, and controls (150.0 6 46.1, 159.7 6 65.5, and 157.5 6 51.1 lm, respectively; P ¼
0.002). Worse MD was the only factor associated with thinner LC (b ¼ 2.344, P < 0.001) and
choroid (b ¼ 1.717, P ¼ 0.009 lm) in PXG eyes. Higher IOP (b ¼ 4.305, P ¼ 0.013) and
worse MD (b ¼ 6.390, P < 0.001) were associated with deeper ALD in PXG.
CONCLUSIONS. In pseudoexfoliation, LC thinning is an early sign, and there is progressive
thinning with advancing glaucoma. Choroidal thinning is observable only with moderate/
advanced glaucoma. In PXG eyes, LC thickness, depth, and peripapillary choroidal thickness
are associated with glaucoma severity.
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Pseudoexfoliation syndrome (PXS) is an age-dependentdisorder characterized by abnormal elastosis and deposition
of microfibril material throughout extracellular matrix system-
ically, including in ocular tissue. PXS is the most recognized
independent risk factor for glaucoma, as approximately half of
patients develop secondary open angle glaucoma (OAG) during
their lifetime, and pseudoexfoliation glaucoma (PXG) globally
accounts for 25% of OAG cases.1 Deposition of pseudoexfolia-
tive material in the trabecular meshwork and blockade of
Schlemm’s canal consequently results in IOP elevation and
development of PXG. In comparison to POAG, PXG is
associated with higher IOP and greater IOP fluctuation. Patients
with PXG more commonly experience failure of medical
management, and overall they are predisposed to faster
progression and a poorer prognosis.2–4 Although the role of
high IOP in PXG has been widely recognized, it has been
suggested that the probability of developing glaucomatous
damage at a given IOP is higher in PXS compared with healthy
controls.3 Therefore, it is suspected that PXS vulnerability
toward glaucoma may be partially attributed to IOP-indepen-
dent factors.1–5
Several studies have suggested the lamina cribrosa (LC) to be
one of the structures affected by abnormal elastosis in PXS.6–8
The LC is a mesh-like structure located at the scleral level,
consisting of collagen beams and pores through which optic
nerve axons traverse, and it is recognized as the primary site of
ganglion cell axonal injury in glaucoma.9 Previous studies have
discussed the association of LC thinning and its displacement
with the existence of glaucoma, including POAG and normal
tension glaucoma (NTG). Findings of these studies suggest that
a defective LC structure could primarily result in glaucomatous
optic neuropathy, despite a normal or controlled IOP.9–11
Previous studies also have reported LC alterations in early
stages of PXS without glaucoma and, similarly, PXG is
associated with thinner LC compared with POAG. Overall, it
has been suggested that the elastotic abnormality of the LC in
PXS could result in decreased stiffness and increased deform-
ability, thereby placing patients at risk of developing glaucoma-
tous optic neuropathy.7,12–14 However, the causality of this
association has not been established thus far.
Many studies have addressed the role of choroidal blood
supply in the development of glaucoma.15–21 Although the
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posterior ciliary arteries supply most of the laminar region of
optic nerve head (ONH), the prelaminar region and surface of
optic disc are primarily supplied by the peripapillary cho-
roid.22 Therefore, choroidal circulation has been suggested to
contribute to the pathophysiology of glaucomatous optic
neuropathy. Findings regarding choroidal involvement in
glaucoma (reflected as choroid thickness) have been discrep-
ant, as several studies reported thinning of the macular or
peripapillary choroid in patients with POAG or NTG,23,24 while
other studies have failed to find a difference in choroidal
thickness in glaucoma as compared with healthy subjects.21,25
Most of these studies have focused on choroid and LC
changes in POAG, and a limited number of investigations have
focused on the changes in LC and choroidal variations in the
full spectrum of the pseudoexfoliation. Further, factors
correlated with choroidal and LC structures in PXG have not
been evaluated. Therefore, the nature of association between
choroidal thickness, LC, and PXG remains unclear. Choroidal
involvement has been a controversial factor in development of
glaucoma in PXS with. There are conflicting results from
several studies describing thinner choroid in PXS and PXG26–28
and other studies that did not find a difference.12,29,30
Spectral-domain optical coherence tomography (SD-OCT) is
an imaging modality that provides a noninvasive cross-sectional
view of the posterior segment of the eye and is widely used for
in vivo evaluation of ONH structures in glaucoma.31 Enhanced-
depth imaging (EDI) SD-OCT has been used for evaluating the
deeper structures of the ONH and choroid by many
investigators.9,11–13,29,30,32,33 The current study aimed to
evaluate LC features and peripapillary choroidal thickness in
PXS patients (with and without glaucoma) using EDI SD-OCT
and to identify factors affecting choroidal thickness and LC in
these patients.
MATERIALS AND METHODS
Patients
This is a case-control cross-sectional study conducted from
September 2013 to September 2017 at Farabi Eye Hospital in
Tehran, Iran. Three groups of subjects were investigated in this
study as follows: (1) pseudoexfoliation eyes with glaucoma
(‘‘PXG’’ group), (2) age-matched PXS eyes without glaucoma
(‘‘PXS’’ group), and (3) age-matched healthy volunteers
(‘‘control’’ group). Controls were selected among individuals
who were referred to the hospital for routine and/or refractive
check-ups. A complete ophthalmic examination was per-
formed for all subjects, including best-corrected visual acuity
measurement (using the Early Treatment Diabetic Retinopathy
Study chart), slit-lamp biomicroscopy, Goldmann applanation
tonometry, gonioscopy, dilated stereoscopic fundus examina-
tion using a 90- or 78-diopter (D) lens, measurement of the
central corneal thickness by pachymetry (Tomey Corporation,
Nagoya, Japan), visual field test (Humphrey Field Analyzer II
750; 24-2 Swedish interactive threshold algorithm; Carl Zeiss
Meditec, Dublin, CA, USA), axial length measurement (IOL-
Master; Carl Zeiss Meditec), and SD-OCT imaging of the ONH
and macula (Spectralis OCT; Heidelberg Engineering, Inc.,
Dossenheim, Germany).
For all study participants, inclusion criteria were as follows:
(1) age above 18 years; (2) best-corrected visual acuity of 0.5
logMAR or better with a spherical equivalent within 5 D and a
cylinder correction within 3 D; and (3) reliable Humphrey
Field Analyzer results with a false-positive error rate less than
15%, a false-negative error rate less than 20%, and a fixation
loss rate less than 20%. The exclusion criteria were as follows:
(1) presence of other intraocular or neurologic disorder that
could cause visual field impairment; (2) history of any ocular
surgery; (3) a diagnosis of glaucoma in the fellow eye; (4) hazy
media interfering with OCT imaging; or (5) history of diabetes
mellitus.
Patients were enrolled in the PXG group if they had (1)
pseudoexfoliation material on the anterior lens capsule and/or
pupillary margin after mydriasis on slit-lamp biomicroscopy;
(2) glaucomatous optic neuropathy (thinning or notching of
the neural rim); (3) glaucomatous visual field defect defined as
a Glaucoma Hemifield Test outside of normal limits and four
abnormal points with P < 5% on the pattern deviation plot,
both confirmed at least once on 24-2 visual fields34; and (4)
history of IOP greater than 21 mm Hg without treatment. The
PXS group were defined as (1) visible pseudoexfoliation
material on the anterior lens capsule and/or pupillary margin
after mydriasis on slit-lamp biomicroscopy; (2) IOP less than 22
mm Hg without treatment; (3) negative history of elevated IOP;
(4) absence of glaucomatous disc appearance (i.e., intact
neuroretinal rim without cupping, notches, or localized
pallor); and (5) a normal standard automated perimetry defined
by mean deviation (MD) and pattern standard deviation (PSD)
within 95% CI limits and a Glaucoma Hemifield Test within
normal limits. The control group was defined as (1) IOP less
than 22 mm Hg without treatment; (2) negative history of
elevated IOP; (3) absence of glaucomatous disc appearance;
(4) normal standard automated perimetry; and (5) absence of
pseudoexfoliation material on the anterior lens capsule or
pupillary margin after mydriasis on slit-lamp biomicroscopy in
both eyes.
This study was approved by the local Ethical Committee of
Tehran University of Medical Sciences and was conducted in
accordance with the Declaration of Helsinki. All patients
provided written informed consent prior to enrollment in the
study.
Spectral-Domain Optical Coherence Tomography
Optic Nerve Head Measurements. All study participants
underwent SD-OCT imaging. Measurements were performed
after pupillary dilation, using SD-OCT (Heidelberg Spectralis
SD-OCT; Spectralis software version 5.3.2; Heidelberg Engi-
neering, Inc.). The EDI-OCT technique in ONH has been
described in previous publications.35 In brief, the SD-OCT
device was set to scan a 158 3 108 rectangle centered on the
ONH. This rectangle was divided into approximately 65
horizontal sections, each of which had an average of 42 OCT
frames. Three sections that passed through the ONH in the
center, midsuperior, and midinferior regions (‘‘Cen,’’ ‘‘Sup,’’
and ‘‘Inf,’’ respectively) were selected, and all study parameters
were measured in each of these frames. To overcome the effect
of choroidal thickness on LC depth measurements, the
sclerochoroid junction reference plane was used for ONH
measurements.36 Figure 1 depicts the LC surfaces and the
sclerochoroidal border in an ONH OCT image. The sclerocho-
roid junction reference line was defined as the line connecting
two points of the anterior scleral surface located at 1750 lm
from the center of the Bruch’s membrane opening (BMO) in
each B scan. All measurements were made perpendicular to
the reference line. Parameters were measured as close as
possible to the vertical center of the ONH. In cases where the
central retinal vessel trunk prevented visualization, measure-
ments were performed on the temporal side. The anterior and
posterior margins of the highly reflective region at ONH
vertical center in the horizontal SD-OCT cross-section were
used as the borders of the LC, and the perpendicular distance
between these borders was identified as LC thickness. The
prelaminar thickness was defined as the distance between the
anterior surface of the optic cup and the anterior border of the
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LC, and the anterior LC depth (ALD) was defined as the
perpendicular distance from the anterior LC surface to the
sclero-choroidal junction (SCJ) line. In a single central B scan,
all the measurements were taken at the following three points:
the maximally depressed point of the anterior surface of LC
and two additional points at 100 and 200 lm temporally from
the maximally depressed point. Only the temporally adjacent
points were selected. The mean of the three measurements
was used for analysis.37 All of the measurements were
performed using HEYEX software 6.0 (Heidelberg Engineering,
Inc.) and analyzed by two masked specialists in two different
sessions.
Choroid Thickness Measurement. According to the
standard protocol for retinal nerve fiber layer (RNFL)
assessment, a 3608 circular scan pattern with 3.4-mm diameter
was used for measuring peripapillary choroidal thickness and
peripapillary RNFL.38 The upper and lower segmentation lines
of the circular scan were manually delineated in order to assess
peripapillary choroid thickness. The lines were adjusted to
align with the inner scleral wall and posterior border of the
RPE to define the outer and inner boundaries of the choroid,
respectively. The choroidal thickness in the investigated
sectors was automatically computed using the RNFL thickness
sectors algorithm (Fig. 1).
Twenty randomly selected EDI-OCT B scans from 20 eyes
were used to assess the intraobserver and interobserver
reproducibility of LC and choroidal thickness measurements.
This analysis was based on two independent series of re-
evaluations performed by two independent examiners. The
absolute agreement of a single observer’s measurements and
FIGURE 1. Top: a peripapillary OCT circular scan depicts the manual segmentation of Bruch’s membrane (upper red line) and sclerochoroidal
border (lower red line) and global thickness of peripapillary choroid as well as six sectors of Heidelberg layout. Bottom: an EDI-OCT of optic nerve
head shows sclerochoroidal border (SCB) and the reference line, anterior and posterior border of LC (yellow arrows), ALD (white arrows), and
prelaminar thickness (B, red arrow) in a raster line across the center of optic nerve.
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the mean of the measurements conducted by two observers
were estimated using the intraclass correlation coefficient
(ICC) via a two-way mixed-effect model. ICC scores 0.75 or
more, 0.40 to 0.75, and 0.4 or less were considered excellent,
moderate, and poor, respectively.39 Scans with quality scores
below 15 were excluded from the analysis. Scans with
inadequate quality as determined by obscured images of
fundus, RNFL interruption, or unclear border of the LC or
posterior choroid were excluded as well.
Statistical Analysis
Continuous variables were reported as mean and SD.
Comparisons between the groups were performed using a
linear mixed model accounting for intereye correlation. The
disease status was used as a nominal parameter in the model,
and the results were reported before and after adjustment for
age, sex, and axial length. In order to evaluate factors
associated with LC/choroid parameters in PXG patients, a
model was built with choroidal and LC thickness as outcome
variables, and variables associated with LC or choroidal
parameters in univariate analysis were reported. A multivariate
model was also designed for LC and choroidal parameters
including age, sex, and variables with both P less than 0.20 in
univariate analysis and variance inflation factor (VIF) less than
3 (to exclude collinearity). An interaction term between age
and PXG status was also fitted in a model to explore if the
relationship between LC/choroid parameters and age was
influenced by disease status. Statistical analyses were per-
formed using statistical software Stata 14.2 (StataCorp LLC,
College Station, TX, USA). P values less than 0.05 were
considered statistically significant.
RESULTS
The current study included 81 eyes of 71 PXG patients, 32 eyes
of 28 PXS patients, and 24 eyes of 23 control subjects. Table 1
depicts the demographics and baseline characteristics of the
participants. The mean age was comparable among the 3
groups (70.4 6 7.7 vs. 69.6 6 7, vs. 66.7 6 6.3 year for PXG,
PXS and control, respectively; P¼0.145). Although there was a
higher proportion of women in the control group (P¼ 0.007),
the three groups were comparable in regard to axial length (P
¼ 0.720) and CCT (P ¼ 0.208). Compared with PXG and PXS
eyes, control eyes had significantly lower IOPs (P¼ 0.002 and
P¼ 0.041, respectively). PXG eyes had worse MD (P < 0.001)
and RNFL thickness globally (P < 0.001) and in each sector
(except the temporal sector). Intraobserver and interobserver
reproducibility of ONH and peripapillary choroid parameters
were excellent and ranged from 0.943 to 0.998 for choroidal
measurements and from 0.827 to 0.998 for ONH measure-
ments.
ONH and LC measurements are demonstrated in Table 2. All
three groups had comparable BMO area (adjusted P ¼ 0.174)
However, there were significant differences in central LC
thickness, which was thinnest in PXG eyes (155.7 6 38.7 lm),
followed by PXS eyes (212.6 6 51.5 lm) and then controls
eyes (271.9 6 61.3 lm) (adjusted P < 0.001, P  0.001 for all
pairwise comparisons). Similarly, inferior and superior LC
thicknesses were thinnest in PXG eyes, followed by PXS eyes
and controls (adjusted P < 0.001; P  0.001 for all pairwise
comparisons). PXG eyes had deeper ALD than PXS (adjusted P
< 0.001) and control eyes (adjusted P ¼ 0.001) in all regions.
However, no significant difference in ALD was observed
between PXS and controls (adjusted P > 0.397 for all regions).
Table 2 shows the peripapillary choroidal thickness among
the three groups. Global peripapillary choroidal thickness was
significantly thinner (131 6 43.7 lm) in PXG eyes than in PXS
(159.7 6 65.5 lm) and control eyes (157.5 6 51.1 lm)
(adjusted P ¼ 0.039). Similar results were found for all the
sectors except the supratemporal, supranasal, and nasal
sectors. PXS and control eyes had comparable choroidal
thickness globally and in all sectors (adjusted P  0.015).
Table 3 presents the results of subgroup analysis in PXG
eyes. Age, sex, spherical equivalent (SE), IOP, and axial length
were comparable between mild PXG and moderate/advanced
PXG (P > 0.161 for all). There were statistically significant
differences in standard structural and functional measurements
between the groups (P < 0.001). Central, inferior, and superior
LC thicknesses were thinner in the moderate/advanced PXG
eyes (138.9 6 37.5, 138.2 6 35.8, and 134.9 6 36.3 lm,
respectively) compared with mild PXG eyes (180.8 6 24.6,
166.5 6 31.3, and 165.6 6 24.5 lm, respectively) (adjusted P
< 0.001 for all the regions). Likewise, moderate/advanced PXG
had deeper ALD compared with mild PXG in all regions
TABLE 1. Clinical and Demographic Characteristics of PXG, PXS, and Control Group
PXG Group
(n ¼ 81)
PXS Group
(n ¼ 32)
Control Group
(n ¼ 24) P* P1† P2† P3†
Age, y 70.4 6 7.7 69.6 6 7 66.7 6 6.3 0.145 0.678 0.085 0.678
Sex (female/male) 18/63 13/19 13/11 0.007 – – –
SE, D 0.70 6 2.05 0.91 6 2.02 0.83 6 1.21 0.916 0.697 0.791 0.893
IOP at presentation, mm Hg 17.2 6 8.1 15.3 6 2.3 13.9 6 2.3 0.005 0.079 0.002 0.041
IOP at OCT examination, mm Hg 16.3 6 5.3 15.3 6 2.3 13.9 6 2.3 0.011 0.248 0.004 0.041
CCT, lm 520.5 6 29.4 518.3 6 28.8 539.6 6 40.2 0.208 0.779 0.115 0.083
Axial length, mm 23.1 6 0.76 22.8 6 0.76 23.3 6 0.73 0.720 0.401 0.532 0.730
Visual field MD, dB 10.1 6 8.7 0.1 6 1.4 0.25 6 1.37 <0.001 <0.001 <0.001 0.694
RNFL, lm
Superotemporal, lm 88.7 6 33.3 121.5 6 19.7 125.0 6 15.5 <0.001 <0.001 <0.001 0.583
Superonasal, lm 78.3 6 27.6 103.2 6 18.6 109.1 6 22.9 <0.001 <0.001 <0.001 0.396
Nasal, lm 57.0 6 19.4 77.0 6 9.7 77.8 6 11.8 <0.001 <0.001 <0.001 0.816
Inferonasal, lm 84.8 6 31.7 121.2 6 21.5 119.2 6 24.2 <0.001 <0.001 <0.001 0.792
Inferotemporal, lm 88.4 6 36.1 118.5 6 28.8 136.6 6 20.0 <0.001 <0.001 <0.001 0.046
Temporal, lm 56.0 6 16.1 61.8 6 13.3 61.3 6 12.7 0.155 0.140 0.107 0.912
Global, lm 70.5 6 20.7 92.2 6 13.3 96.1 6 11.5 <0.001 <0.001 <0.001 0.230
* Linear mixed model.
† P1: Pairwise comparison between PXG and PXS groups; P2: pairwise comparison between PXG and control groups, pairwise comparison
between PXS and control groups. The disease status was used as a nominal parameter in the model. P values <0.05 are shown in bold.
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(adjusted P < 0.010 for all regions). Moderate/advanced PXG
eyes had thinner peripapillary choroid than mild PXG eyes
globally and in each sector (adjusted P < 0.001 for all regions).
Overall, central LC thickness progressively decreased from
controls to PXS to mild PXG to moderate/advance PXG
(adjusted P < 0.001). ALD was deeper in moderate/advanced
and mild PXG eyes compared with PXS and healthy controls
(adjusted P < 0.001). Although moderate/advanced PXG eyes
had the thinnest choroid, choroidal thickness was comparable
in mild PXG, PXS, and control eyes (adjusted P ¼ 0.002) (Fig.
2).
Factors associated with laminar and choroidal measure-
ments in PXG eyes in univariate and multivariate analyses are
demonstrated in Table 4 and Figure 3. RNFL (VIF > 3) was not
included in the multivariable analysis to reduce collinearity in
the final model. Older age, worse MD, and thinner RNFL were
associated with thinner LC thickness in univariate analysis. In
multivariate analysis, only worse MD was associated with
thinner LC (b ¼ 2.344, P < 0.001). Factors associated with
deeper central ALD in univariate analysis included thinner
RNFL and worse MD. When fitted in a multivariate model,
higher IOP (b¼4.305, P¼0.013) and worse MD (b¼6.390, P
< 0.001) were associated with deeper ALD in PXG eyes. Worse
MD was the only factor associated with thinner choroid in both
univariate and multivariate (b ¼ 1.717, P ¼ 0.009) analyses.
We also explored whether the relationships between LC
thickness, ALD, or choroidal thickness and age were influenced
by disease status. Older age was associated with thinner LC (P
¼ 0.040), and the relationship between age and LC thickness
was not affected by disease status (P ¼ 0.873). No link was
found between age and ALD in PXG eyes (P¼ 0.500), and PXG
status had no influence on the association between ALD and
age (P ¼ 0.124). Older age was not associated with thinner
choroid in PXG eyes (b ¼1.09 lm/y, P ¼ 0.080), and these
eyes had a lower rate of choroidal thinning each year (P ¼
0.046) compared with control eyes (b ¼ 3.72 lm/y, P ¼
0.002).
DISCUSSION
In this in vivo human study, we demonstrated a stepwise
increase in LC thickness and stepwise decrease in LC depth
from controls to PXS to mild PXG to advanced PXG. Although
the peripapillary choroid was thinner in moderate/advance
PXG, the other groups of mild PXG, PXS, and controls had
comparable choroidal thickness. In PXG eyes, LC thickness,
depth, and peripapillary choroidal thickness were associated
with glaucoma severity.
Deformation and displacement of the LC have been
implicated as the primary pathophysiologic mechanism of
glaucomatous optic neuropathy.9–11 The thinning of the LC in
various types of glaucoma has been documented in previous
reports.9,11–13,32,33 In a study by Park and associates,40 LC was
thinner in the NTG group than in the POAG and control
groups. In their study comparing LC thickness in glaucomatous
patients, Kim et al.13 observed that despite similar mean IOP,
the LC was significantly thinner in PXG than POAG. In our
previous report, the LC was significantly thinner in non-
glaucomatous PXS patients than in controls. In the present
study, LC was thinnest in moderate to advanced glaucoma,
followed by mild glaucoma, then PXS, and then healthy
controls. Our results suggest that LC changes can occur in
pseudoexfoliatives eye even before IOP elevation, as eyes with
IOP greater than 21 mm Hg were excluded from PXS group in
our study.
TABLE 3. Comparison of Clinical and Demographic Characteristics, ONH Measurements, and Choroidal Thickness in Different Peripapillary
Locations in PXG Eyes According to Severity of Glaucoma
Moderate/Advanced PXG
(n ¼ 47)
Mild PXG
(n ¼ 34) P* Adjusted P†
Age, y 69.9 6 7 71 6 8.6 0.552 –
Sex (female/male) 10/37 8/26 0.810 –
SE, D 0.85 6 1.89 0.50 6 2.27 0.559 –
IOP at presentation, mm Hg 17.3 6 9.2 17.2 6 6.3 0.976 –
IOP at OCT examination, mm Hg 16.1 6 5.7 16.6 6 4.7 0.672
CCT, lm 514.5 6 27.3 528.6 6 31.1 0.161 –
Axial length, mm 23.13 6 0.77 23.27 6 0.75 0.473 –
Visual field MD (dB) 15.0 6 7.7 2.7 6 1.5 <0.001 –
Global RNFL, lm 57.9 6 14.9 87.6 6 13.8 <0.001 –
ONH structure
BMO, lm 1546.1 6 157.3 1552.9 6 156 0.864 0.836
Cen Prelaminar thickness, lm 163.1 6 101.6 199.6 6 138.7 0.296 0.202
Cen ALD, lm 306.7 6 105.3 209.5 6 79.7 <0.001 <0.001
Cen LC thickness, lm 138.9 6 37.5 180.8 6 24.6 <0.001 <0.001
Sup ALD, lm 349.5 6 115.1 263.7 6 74.1 0.001 0.001
Sup LC thickness, lm 138.2 6 35.8 166.5 6 31.3 0.002 0.008
Inf ALD, lm 294.9 6 105.7 233.1 6 85.4 0.016 0.010
Inf LC thickness, lm 134.9 6 36.3 165.6 6 24.5 <0.001 0.001
Choroidal thickness
Superotemporal, lm 134.6 6 47.1 160.3 6 47.3 0.026 0.015
Superonasal, lm 131.2 6 42.7 164.2 6 56.4 0.010 0.005
Nasal, lm 116.8 6 39.3 160.1 6 63.2 0.003 0.001
Inferonasal, lm 91.7 6 37.0 125.7 6 46.2 0.003 <0.001
Inferotemporal, lm 95.2 6 33.5 123.6 6 43.4 0.003 0.001
Temporal, lm 124.4 6 45.1 151.4 6 46.2 0.014 0.004
Global, lm 117.2 6 36.6 150.0 6 46.1 0.003 0.003
* Linear mixed model. The disease status was used as a nominal parameter in the model.
† Adjusted for age, sex, IOP, and axial length. P values <0.05 are shown in bold.
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Generalized ultrastructural alterations in ocular tissues and
other organs in patients with pseudoexfoliation have been
previously demonstrated.41 Significant downregulation of lysyl
oxidase-like 1 and elastic fiber in LC tissues in PXS eyes
(without and with glaucoma) compared with normal and
POAG specimens has been shown in vitro.7 These alterations
may lead to reduced elasticity of the LC14 and may place PXS
patients at higher risk of glaucomatous damage. Thinning of
the LC, besides being a consequence of glaucomatous damage,
could also have prognostic and mechanistic significance and
may predispose the eye to faster glaucomatous progression.42
Lee and associates,42 in a recent study on POAG eyes,
demonstrated that a thinner LC is associated with a faster rate
of RNFL thinning. A thinner LC may be the result of LC
compression, interindividual variation, or both; whichever the
case, the thinner LC may affect disease progression.
FIGURE 2. Distribution of central LC thickness (top left), central LC depth (top right), and, global choroidal thickness (bottom left), in four eye
groups (moderate/advanced PXG, mild PXG, PXS, and healthy controls) assessed by OCT. Adjusted P values for pairwise comparison are provided.
FIGURE 3. The scatterplots demonstrating the association between central laminar thickness and MD (right), the association between central
laminar depth and MD (middle), and the association between global choroidal thickness and MD (left) in eyes with PXG. Linear and quadratic R2 for
the models are provided.
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The association between LC thickness and glaucoma
severity differed depending on the type of glaucoma. Park et
al.40 also reported a logarithmic correlation between LC
thickness and retinal sensitivity in POAG eyes. Similarly, a
small but significant correlation between glaucoma severity
(represented by MD) and LC thickness and depth were found
by Kim et al.33 using EDI SD-OCT. Although LC thickness was
correlated with MD in the POAG group, the NTG group did not
show a significant correlation with disease severity. The
investigators proposed that the structural properties of the
LC might be different between NTG and high-tension glaucoma
eyes. In the current study, we found that LC thickness
decreased with disease progression in PXG, similar to in
POAG. In this study, age was associated with LC thickness in
univariate but not multivariate analysis.
In the current study, PXG eyes had deeper ALD compared
with PXS and healthy controls. Deepening of the anterior LC
surface has been well documented in glaucomatous eyes and is
considered to be the principal pathogenic event leading to
axonal damage.11,33,42,43 This event may cause a blockade of
axoplasmic flow by kinking and pinching the retinal ganglion
cell axons passing through it, thereby provoking glaucomatous
optic nerve damage.43 Deeper LC has been linked to more
rapid glaucomatous damage in a recent study.42
Several factors have been reported to be associated with the
status and the magnitude of the LC deformation in POAG,
including age,44,45 IOP,46,47 disease severity,10,33,45 and pheno-
type of the glaucomatous disc.48 However, no study has
reported the factors related to LC depth in PXG thus far. In
POAG eyes, age appears to be one associated factor,44,45 as
older eyes have less LC deformation than younger eyes for the
same level of functional loss. Investigators attributed that
difference to changes in the elasticity of lamina and to different
responses of lamina to IOP in older individuals. In the present
study, no link was found between age and ALD in PXG eyes.
The characteristic changes in the LC may occur at younger ages
in pseudoexfoliative patients, which could explain the lack of
association between age and ALD in PXG.
Another factor is disease severity, in which greater LC
deepening is observed in more advanced glaucoma.49 A recent
report by Ren et al.45 showed an association between the ALD
and MD in early glaucoma or ocular hypertension patients.
However, in their study, the LC depth increased with worse VF
status in younger eyes, but not older eyes. Kim et al.13 reported
the LC depth was significantly correlated with the MD in NTG
eyes, but not POAG. In agreement with the results in NTG
eyes, our study concluded that the LC was deeper in PXG eyes
compared with controls and that the LC depth was associated
with disease severity.
Our data showed a significant association between IOP and
ALD in PXG after adjustment for confounders. Previous animal
studies reported posterior displacement of the LC at increasing
IOP.47 Using EDI in POAG eyes, Kim et al.46 found a significant
association of LC depth with baseline IOP, but not IOP at the
time of study examination. Even though many of our patients
were under intensive IOP-lowering management, a link
between IOP at presentation and the LC depth was detected.
This discrepancy might be due to the relative irreversibility of
LC displacement secondary to specific characteristics of PXG
eyes, which have been shown in experimental animal
models.14 We also did not find any significant difference in
LC depth between PXS and control eyes, suggesting that LC
thinning might occur before LC deepening.
In the present study, LC depth was measured relative to the
anterior scleral surface. Previous studies have used the BMO as
a reference plane. However, recent cross-sectional studies have
shown that BMO is not a stable reference due to significant
thinning of the choroid and posterior migration of the BMOT
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with aging.20,21 Alternatively, the anterior scleral surface has
been found as a reference that could eliminate the influence of
choroidal thickness.36,48 This definition was necessary to avoid
bias in our study, as choroidal thickness was thinner in more
advanced stages of PXG.
Previous studies evaluating the choroidal thickness in
glaucomatous eyes as a marker of choroidal blood flow have
reported conflicting results.15–21 In a meta-analysis of 22
studies, Zhang et al.21 suggested that POAG was not
significantly associated with a marked thinning or thickening
of the choroid based on EDI-OCT measurements. Nevertheless,
the type of glaucoma may affect choroidal thickness. In the
present study, the choroidal thickness was comparable among
mild PXG, PXS, and controls. There are various studies
investigating whether retrobulbar hemodynamics change in
PXG.50,51 Galassi et al.50 determined that retrobulbar hemody-
namics were impaired in PXG compared with POAG and
healthy controls, which the investigators interpreted as the
presence of impaired ocular vascular regulation in PXG. Turan-
Vural et al.28 reported decreased subfoveal choroidal thickness
in nonglaucomatous PXS eyes compared with healthy controls.
In contrast, Moghimi et al.12,30 did not show any difference in
peripaillary and macular choroidal thickness in PXS eyes
compared with controls after adjusting for age and axial length.
Likewise, You et al.52 reported that PXS was not associated
with the choroidal thickness in the Beijing Eye Study 2011.
Although Ozge et al.29 demonstrated that peripapillary
choroidal thickness was comparable in PXG eyes and healthy
controls, another recent study found choroidal thickness to be
thinner in the nasal quadrant of macula in PXG eyes.15
Similarly, Dursun et al.16 compared the choroidal thickness of
30 PXS eyes, 28 PXG eyes, and 30 age-matched healthy eyes
and found a nonstatistically significant thinner choroid in PXG
compared with PXS. However, all these studies analyzed
patients affected by early or moderate glaucoma, with an
average MD always better than 12 dB. In the present study,
we showed that moderate to advanced PXG eyes had thinner
choroid when compared with mild PXG, PXS, and healthy
controls. This observation suggests that choroidal thickness
occurs later in the disease course of pseudoexfoliation and that
factors other than choroidal thinning may play a role in the
conversion from PXS to PXG. Sacconi and associates24 have
also reported choroidal thinning in advanced POAG. Never-
theless, due to limited information on the relationship between
choroidal blood flow and choroidal thickness in humans, we
are unable to conclude based on our results whether choroidal
blood flow was normal in eyes with early stages of
pseudoexfoliation despite having choroidal thickness within
the normal range.
Although many investigators have shown significant links
between demographics, ocular parameters, and choroidal
thickness in healthy and POAG eyes, no study has evaluated
factors related to choroidal thicknesses in patients with PXG.
Roberts and associates23 found that choroidal thickness was
inversely associated with age and axial length. Similarly,
Mwanza and associates20 found a similar association of age
with axial length, but not with IOP or blood pressure.
Conversely, in a study on PXS eyes, Moghimi et al.12 showed
no links between choroidal thickness and age, axial length, and
CCT. In the present study, glaucoma severity was the only
factor that correlated with choroidal thickness in PXG eyes.
Although the MD was not correlated with choroidal thickness
in POAG eyes,25 one recent study showed choroidal thinning
in advanced POAG24 and concluded that the longer duration of
glaucoma may lead to ocular changes like vascular impairment
and diffuse loss of choroidal vessels.
Several limitations must be acknowledged in this study. As
we defined the PXS group to have normal IOP, some of the
differences between the PXG eyes and controls may be
underestimated. This is especially true for ALD, as it has been
well-described that IOP can alter this parameter.10,33,53 The
operating software of the Heidelberg Spectralis OCT did not
provide automatic segmentation of the choroid and LC.
Manual segmentation may introduce some inaccuracy,
although the intraobserver and interobserver ICCs all were
more than 0.99 for choroid and 0.83 for LC parameters in this
study. While EDI substantially improved the image quality of
the LC, it was still difficult to determine the border of the LC
in some images (16% of PXG, 27% of PXS, and 29% of
controls). Thus, our analysis was limited to eyes demonstrat-
ing a clear border of LC, which may have biased the results
similar to other LC imaging studies using EDI technology. A
recent study using a single line scan on three OCT devices
showed that the anterior LC was the most detectable feature,
followed by the LC insertions and then the posterior
boundary; and that LC visibility was not affected by glaucoma
severity.36 However, several cohorts evaluated LC thickness
and posterior boundary in different eye diseases and used the
EDI three-dimensional raster scan pattern to improve
detection.13,32,33,42 In this method, it is possible to view
multiple successive B scans within a volume to look for
consistent visual clues that may help to identify the posterior
laminar surface. We used the same protocol to detect the LC
surfaces of the study cases with improved precision.
Most of the PXG eyes were under intensive IOP-lowering
therapy and the information about baseline IOP was not
available. Therefore, the relationship between baseline IOP
(untreated IOP) and OCT parameters could not be evaluated.
Finally, it is not possible to determine the cause-effect
relationship between LC and choroidal characteristics and
disease severity because of the cross-sectional nature of the
study and the lack of POAG eyes as a comparison group. One
could argue that these changes in the choroid and ONH may
occur in any glaucomatous process and might not be specific
to pseudoexfoliation. Further prospective, longitudinal study is
warranted.
To summarize, LC thinning occurs early in pseudoexfolia-
tion and its extent is linked to glaucoma severity. Although LC
posterior displacement was associated with diagnosis of
glaucoma and severity, choroidal thinning may not be detected
until late in the disease course.
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